JP2025029014A5 - - Google Patents

Download PDF

Info

Publication number
JP2025029014A5
JP2025029014A5 JP2024207476A JP2024207476A JP2025029014A5 JP 2025029014 A5 JP2025029014 A5 JP 2025029014A5 JP 2024207476 A JP2024207476 A JP 2024207476A JP 2024207476 A JP2024207476 A JP 2024207476A JP 2025029014 A5 JP2025029014 A5 JP 2025029014A5
Authority
JP
Japan
Prior art keywords
gbs
streptococcus
viii
disease
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024207476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025029014A (ja
JP7871358B2 (ja
Filing date
Publication date
Priority claimed from PCT/IB2021/057714 external-priority patent/WO2022043855A1/en
Application filed filed Critical
Publication of JP2025029014A publication Critical patent/JP2025029014A/ja
Publication of JP2025029014A5 publication Critical patent/JP2025029014A5/ja
Application granted granted Critical
Publication of JP7871358B2 publication Critical patent/JP7871358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024207476A 2020-08-26 2024-11-28 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用 Active JP7871358B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202063070410P 2020-08-26 2020-08-26
US63/070,410 2020-08-26
US202163229359P 2021-08-04 2021-08-04
US63/229,359 2021-08-04
PCT/IB2021/057714 WO2022043855A1 (en) 2020-08-26 2021-08-23 Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
JP2023512646A JP2023538736A (ja) 2020-08-26 2021-08-23 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023512646A Division JP2023538736A (ja) 2020-08-26 2021-08-23 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用

Publications (3)

Publication Number Publication Date
JP2025029014A JP2025029014A (ja) 2025-03-05
JP2025029014A5 true JP2025029014A5 (cg-RX-API-DMAC7.html) 2025-06-16
JP7871358B2 JP7871358B2 (ja) 2026-06-08

Family

ID=77519437

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023512646A Pending JP2023538736A (ja) 2020-08-26 2021-08-23 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用
JP2024207476A Active JP7871358B2 (ja) 2020-08-26 2024-11-28 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023512646A Pending JP2023538736A (ja) 2020-08-26 2021-08-23 B群レンサ球菌多糖-タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用

Country Status (7)

Country Link
US (1) US20230321212A1 (cg-RX-API-DMAC7.html)
EP (1) EP4203995A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023538736A (cg-RX-API-DMAC7.html)
KR (1) KR20230056727A (cg-RX-API-DMAC7.html)
AU (1) AU2021332183B2 (cg-RX-API-DMAC7.html)
CA (1) CA3192786A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022043855A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4203995A1 (en) * 2020-08-26 2023-07-05 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
EP4622665A2 (en) * 2022-11-22 2025-10-01 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2026038177A1 (en) 2024-08-16 2026-02-19 Pfizer Inc. Immunogenic compositions and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360897A (en) 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
EP0625910B1 (en) 1992-02-11 2003-07-23 Henry M. Jackson Foundation For The Advancement Of Military Medicine Dual carrier immunogenic construct
DK0616034T3 (da) 1993-03-05 2005-02-21 Wyeth Corp Plasmid til fremstilling af CRM-protein og diphtheria toxin
EP0720485B1 (en) 1993-09-22 2003-11-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
DE69628418T2 (de) 1995-03-22 2004-04-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
HU228264B1 (en) 2000-06-08 2013-02-28 Intercell Ag Immunostimulatory oligodeoxynucleotides
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
WO2002098368A2 (en) 2001-06-07 2002-12-12 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
US7332174B2 (en) 2001-06-07 2008-02-19 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
US20040096461A1 (en) * 2002-07-30 2004-05-20 Baxter Healthcare Corporation Chimeric multivalent polysaccharide conjugate vaccines
EP1603950A2 (en) 2003-03-17 2005-12-14 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
IL308456A (en) 2005-04-08 2024-01-01 Wyeth Llc A multivalent pneumomuroral protein-polysaccharide conjugate preparation
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
PL1866342T3 (pl) 2005-04-08 2019-04-30 Wyeth Llc Oddzielanie zanieczyszczeń od polisacharydu Streptococcus pneumoniae przez manipulację pH
CA2665169C (en) 2006-10-10 2017-02-21 Wyeth Purification of streptococcus pneumoniae type 3 polysaccharides
HUE039169T2 (hu) 2007-03-23 2018-12-28 Wyeth Llc Rövidített tisztítási eljárás Streptococcus pneumoniae tok-poliszacharidok elõállítására
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
CN104582718B (zh) 2012-10-03 2017-10-24 诺华股份有限公司 免疫原性组合物
RU2672053C2 (ru) 2012-12-20 2018-11-09 Пфайзер Инк. Способ гликоконъюгации
KR102143534B1 (ko) * 2015-05-04 2020-08-12 화이자 인코포레이티드 B군 스트렙토코쿠스 폴리사카라이드-단백질 접합체, 접합체를 생산하는 방법, 접합체를 포함하는 면역원성 조성물, 및 그의 용도
EP3316904A1 (en) * 2015-07-01 2018-05-09 GlaxoSmithKline Biologicals S.A. Immunogenic compositions
US10751402B2 (en) * 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
EP3638301A1 (en) * 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
EP4203995A1 (en) * 2020-08-26 2023-07-05 Pfizer Inc. Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

Similar Documents

Publication Publication Date Title
JP2019526621A5 (cg-RX-API-DMAC7.html)
JP2024009978A5 (cg-RX-API-DMAC7.html)
JP2022542316A5 (cg-RX-API-DMAC7.html)
JP2021512870A5 (cg-RX-API-DMAC7.html)
JP2019526620A5 (cg-RX-API-DMAC7.html)
MX2022001241A (es) Composiciones de conjugados neumococicos multivalentes polisacarido - proteina y metodos para usar los mismos.
JP2021505589A5 (cg-RX-API-DMAC7.html)
JP2020533437A5 (cg-RX-API-DMAC7.html)
MY145150A (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
HRP20161681T1 (hr) Cjepivo protiv bakterije streptococcus pneumoniae
JP2020533438A5 (cg-RX-API-DMAC7.html)
CY1114041T1 (el) Ενεσιμα εμβολια εναντι πολλαπλων οροομαδων μηνιγγιτιδοκοκκου
RU2012116119A (ru) Множественная вакцинация, включающая менингококки серогруппы с
JP2004501873A5 (cg-RX-API-DMAC7.html)
JP2007507487A5 (cg-RX-API-DMAC7.html)
HRP20100211T1 (hr) Imunogeni pripravak
JP2008543908A5 (cg-RX-API-DMAC7.html)
MX336934B (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
WO2019152925A8 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
HK1043730A1 (zh) 抗肺炎鏈球菌莢膜多糖的疫菌
JP2022513562A5 (cg-RX-API-DMAC7.html)
WO2008079732A3 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
JP2010513549A5 (cg-RX-API-DMAC7.html)
JP2005508849A5 (cg-RX-API-DMAC7.html)
JP2008543907A5 (cg-RX-API-DMAC7.html)